About Institute for Translational Research
At HKSTP, we turn scientific discoveries into life-changing biomedical innovations.
The Institute for Translational Research (ITR) is home to this significant work. We make this transformation possible with our Research to Innofacturing to Finance (R-I-F) value chain, empowering innovators to shape a healthier world with InnoHK collaborations, InnoPark’s advanced manufacturing, and Hong Kong’s huge investor pool.
With powerful connections with the government, academia, as well as investment and biotech communities, we are equipped to provide comprehensive support for translational research in the healthcare landscape.
Researchers will find inspiration from ITR’s vibrant community, which has grown from 50 to 180 biotech companies in the last five years, as well as our successful InnoHK collaborations with globally renowned health scientists. Our tailored programmes and the over 1,000 collaborators within our reach also help develop their skills and enrich their discoveries.
To this day, our growing world-class ecosystem continues to produce top-notch biotech innovations that benefit not just Hong Kong but also the global community.
Hong Kong’s Advantage as a Biotech Hub
Having ranked as the #1 IPO venue globally in the last 12 years, Hong Kong provides biotech startups a platform to shine.
Empower your discoveries with this international city’s leading universities—3 of them in the world’s Top 50, and first-rate biomedical researchers. As the second largest biotech funding hub worldwide and a gateway to the vast markets of Mainland China, Hong Kong also connects you to exciting business opportunities to propel your biotech innovations forward.
Ready to grow with 1,000+ biotech investors and collaborators within ITR? Explore our lab facilities by taking the 360o Virtual Tour. Contact institute@hkstp.org to learn more about how we can build a healthier world together.
Our Partners
Programmes enabling biotech startups at every stage
With our deep knowledge of our startups’ needs, we have built, and are continuously building, customer-centric programs to enable every journey. Supporting a wide spectrum of technologies at every stage, our core facilities are second to none, with some of these state-of-the-art facilities exclusively available at the Hong Kong Science Park.
Technology Type
 |
 |
 |
 |
 |
 |
 |
 |
||
| Discovery | Pre-Clinical | IND  IND : Investigational New Drug |
Clinical Phase I |
Clinical Phase II |
Clinical Phase III |
NDA/MAA NDA: New Drug Application MAA: Marketing Authorization Application |
Post-market | ||
| IncuBio | |||||||||
| Biomedical Technology Support Center (BSC) | |||||||||
| Chemical Co-working(CCC) | |||||||||
| Biobank and Histopathology Services | |||||||||
| Good Laboratory Practice Drug Safety Testing Center (DSC) * | |||||||||
| HKSTP Independent Ethics Committee (IEC) | |||||||||
| Medical Device Testing Lab | |||||||||
| Sensor Lab | |||||||||
| STP platform | |||||||||
| MedTech Co-create Programme | |||||||||
| Clinical Translational Catalyst (CTC) | |||||||||
| Good Manufacturing Practice (GMP) (cells) * | |||||||||
| Healthy ageing platform | |||||||||
* First in Hong Kong
Media Highlights
Contact Us